Daily Derm Times: July 22, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Practical Pearls for Managing Vitiligo Across Skin Types and Life Stages

Topical ruxolitinib, phototherapy, and psychosocial care took center stage in an interactive discussion between Seemal Desai, MD, FAAD, and colleagues, on managing complex vitiligo cases.

FDA Issues CRL for RP1 and Nivolumab in Melanoma

Replimune faces FDA challenges for RP1's approval in advanced melanoma, highlighting complexities in cancer drug development and regulatory scrutiny.

Social Media Fails on Retinol Safety Education

Social media spreads significant retinol misinformation, risking adolescent skin health. Experts call for improved digital education and accurate content creation.

Beyond Efficacy: Why We Need a New Look at Drug Safety

Matthew Zirwas, MD, discusses the complexities of safety analysis in psoriasis clinical trials, advocating for exposure-adjusted incidence rates to enhance risk communication.

Sun Pharma Announces Positive Phase 3 Results for Tildrakizumab in Psoriatic Arthritis

Sun Pharma reveals promising phase 3 results for tildrakizumab (Ilumya) in treating PsA, showing significant symptom improvement in patients.

Claire Fuller, MA, FRCP: WHA Resolution on Skin Diseases Marks a Skin Diseases Marks a Global Turning Point for Dermatologic Health

A new WHA resolution spotlights skin health, pushing member states to close care gaps and integrate dermatology into public health.

Lars French, MD: Turning Global Skin Health Policy into Action for Patients

Lars French, MD, explains how the new WHA resolution on skin health could drive training, access, and global policy change.

Psychological Stress Impairs Wound Healing and Collagen Production, New Review Confirms

Updated research finds that chronic stress disrupts healing processes and scar treatments, limiting the effectiveness of wound care in some patients.